Cargando…
Delivery luteolin with folacin-modified nanoparticle for glioma therapy
BACKGROUND: Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteo...
Autores principales: | Wu, Cong, Xu, Qian, Chen, Xinyue, Liu, Jiagang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754621/ https://www.ncbi.nlm.nih.gov/pubmed/31571861 http://dx.doi.org/10.2147/IJN.S214585 |
Ejemplares similares
-
Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo
por: Zheng, Songping, et al.
Publicado: (2017) -
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
por: Zhu, Yuanyuan, et al.
Publicado: (2023) -
Luteolin-Loaded Nanoparticles for the Treatment of Melanoma
por: Fu, Qiao-Ting, et al.
Publicado: (2023) -
ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment
por: Tan, Chen, et al.
Publicado: (2022) -
Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment
por: Wang, Yu, et al.
Publicado: (2021)